Interacting Drugs |
Bacitracin, neomycin, polymyxin B, and hydrocortisone vs CycloSPORINE (Systemic) |
Security Level |
|
Mechanism |
CycloSPORINE (Systemic): Aminoglycosides may enhance the nephrotoxic effect of CycloSPORINE (Systemic). |
Management |
Monitor therapy |
Bacitracin, neomycin, polymyxin B, and hydrocortisone vs CycloSPORINE (Systemic)
Post Review about Bacitracin, neomycin, polymyxin B, and hydrocortisone vs CycloSPORINE (Systemic) Click here to cancel reply.
Other Interactions of CycloSPORINE (Systemic)
Latest News
- FDA approves Ruconest for treatment of hereditary angioedema
- FDA recommend against aspirin to prevent First Heart Attacks
- FDA approves Pomalyst (pomalidomide) for advanced multiple myeloma
- FDA approves three new drug treatments for type 2 diabetes
- Long-term consequences of vaginal delivery on the pelvic floor
No comments yet.